Low HDL-C can be a biomarker to predict persistent severe AKI in septic patients? A retrospective cohort study

Table 2 Differences between the high HDL-C group and the low HDL-C group

N	Low HDL-C	High HDL-C	p overall
N	N = 300	N = 304
Persistent severe SA-AKI, N%	56 (18.7%)	32 (10.5%)	0.007
APSIII	57.0 [42.0;82.0]	52.0 [41.0;66.0]	0.001
SOFA Score	7.00 [5.00;11.0]	5.50 [4.00;7.00]	< 0.001
Non renal SOFA Score	6.00 [4.00;9.00]	4.50 [3.00;6.00]	< 0.001
RRT, N%	43 (14.3%)	20 (6.58%)	0.003
Vasopressor, N%	150 (50.0%)	124 (40.8%)	0.028
Scr (mg/dl)	1.30 [0.90;2.20]	1.20 [0.80;1.70]	0.004

SA-AKI Sepsis associated acute kidney injury, APS III Acute Physiology Score III, SOFA Sequential Organ Failure Assessment, KRT Renal replacement therapy, HDL-C high density lipoprotein cholesterol, Scr Serum creatinine

ISSN: 2047-783X